Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Baxter
AstraZeneca
Merck
Moodys

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

LUPRON DEPOT-PED Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Lupron Depot-ped patents expire, and when can generic versions of Lupron Depot-ped launch?

Lupron Depot-ped is a drug marketed by Abbvie Endocrine Inc and is included in one NDA.

The generic ingredient in LUPRON DEPOT-PED is leuprolide acetate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.

Drug patent expirations by year for LUPRON DEPOT-PED
Recent Clinical Trials for LUPRON DEPOT-PED

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Aging (NIA)Phase 2
Weill Medical College of Cornell UniversityPhase 2
University of North Carolina, Chapel HillPhase 2

See all LUPRON DEPOT-PED clinical trials

Recent Litigation for LUPRON DEPOT-PED

Identify potential future generic entrants

District Court Litigation
Case NameDate
Ferring B v. v. Watson Laboratories Inc.2014-04-17
TAKEDA PHARMACEUTICAL CO. LTD. v. DUDAS2006-09-22
NOVARTIS CORPORATION v. TEVA PHARMACEUTICALS USA INC2004-09-16

See all LUPRON DEPOT-PED litigation

US Patents and Regulatory Information for LUPRON DEPOT-PED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-003 Apr 16, 1993 DISCN Yes No   Start Trial   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-008 Aug 15, 2011 RX Yes Yes   Start Trial   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-005 Jan 21, 1994 RX Yes Yes   Start Trial   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-004 Apr 16, 1993 DISCN Yes No   Start Trial   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-002 Apr 16, 1993 RX Yes Yes   Start Trial   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-006 Jan 21, 1994 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LUPRON DEPOT-PED

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-005 Jan 21, 1994   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-002 Apr 16, 1993   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-008 Aug 15, 2011   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-005 Jan 21, 1994   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-008 Aug 15, 2011   Start Trial   Start Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-003 Apr 16, 1993   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Dow
Baxter
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.